Senate - 10/29/2019 Received in the Senate and Read twice and referred to the Committee on Finance. (All Actions)
Tracker:
This bill has the status Passed House
Here are the steps for Status of Legislation:
Introduced
Array
(
[actionDate] => 2019-10-28
[displayText] => Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
[externalActionCode] => 5000
[description] => Introduced
[chamberOfAction] => House
)
Passed House
Array
(
[actionDate] => 2019-10-28
[displayText] => Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
[externalActionCode] => 8000
[description] => Passed House
[chamberOfAction] => House
)
To amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.
Actions Overview (4)
Date
Actions Overview
10/28/2019
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
10/28/2019
Committee on Ways and Means discharged.
10/28/2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
03/14/2019
Introduced in House
10/28/2019 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
10/28/2019 Committee on Ways and Means discharged.
10/28/2019 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
03/14/2019 Introduced in House
All Actions (18)
Date
Chamber
All Actions
10/29/2019
Senate
Received in the Senate and Read twice and referred to the Committee on Finance.
10/28/2019-7:47pm
House
Motion to reconsider laid on the table Agreed to without objection.
10/28/2019-7:47pm
House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)
10/28/2019-7:37pm
House
DEBATE - The House proceeded with forty minutes of debate on H.R. 1781.
10/28/2019-7:37pm
House
Considered under suspension of the rules. (consideration: CR H8526-8527)
10/28/2019-7:37pm
House
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
10/28/2019
House
Placed on the Union Calendar, Calendar No. 205.
10/28/2019
House
Committee on Ways and Means discharged.
10/28/2019
House
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
04/03/2019
House
Ordered to be Reported (Amended) by Voice Vote. Action By: Committee on Energy and Commerce
04/03/2019
House
Committee Consideration and Mark-up Session Held. Action By: Committee on Energy and Commerce
03/27/2019
House
Forwarded by Subcommittee to Full Committee by Voice Vote . Action By: House Energy and Commerce Subcommittee on Health
03/27/2019
House
Subcommittee Consideration and Mark-up Session Held. Action By: House Energy and Commerce Subcommittee on Health
03/15/2019
House
Referred to the Subcommittee on Health. Action By: Committee on Energy and Commerce
03/14/2019
House
Referred to the Subcommittee on Health. Action By: Committee on Ways and Means
03/14/2019
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/14/2019
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/14/2019
House
Introduced in House
10/29/2019 Received in the Senate and Read twice and referred to the Committee on Finance.
10/28/2019 Motion to reconsider laid on the table Agreed to without objection.
10/28/2019 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)
10/28/2019 DEBATE - The House proceeded with forty minutes of debate on H.R. 1781.
10/28/2019 Considered under suspension of the rules. (consideration: CR H8526-8527)
10/28/2019 Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
10/28/2019 Placed on the Union Calendar, Calendar No. 205.
10/28/2019 Committee on Ways and Means discharged.
10/28/2019 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
04/03/2019 Ordered to be Reported (Amended) by Voice Vote.
04/03/2019 Committee Consideration and Mark-up Session Held.
03/27/2019 Forwarded by Subcommittee to Full Committee by Voice Vote .
03/27/2019 Subcommittee Consideration and Mark-up Session Held.
03/15/2019 Referred to the Subcommittee on Health.
03/14/2019 Referred to the Subcommittee on Health.
03/14/2019 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/14/2019 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.
A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.
Related bill
CRS
03/14/2019 Read twice and referred to the Committee on Finance.
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
Shown Here: Introduced in House (03/14/2019)
Payment Commission Data Act of 2019
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.